Renowned Cardiologist from Cleveland Clinic engages with medical fraternity at CK Birla Hospitals, Jaipur ahead of World Heart Day
In the run-up to World Heart Day, CK Birla Hospitals, Jaipur organized an interactive session featuring world renowned cardiologist Dr. Samir Kapadia, Chairman of Cardiovascular Medicine and Director of Cardiology at Cleveland Clinic in the USA.
City Air News
Sep 19, 2025 11:36
0
Jaipur, September 19, 2025: In the run-up to World Heart Day, CK Birla Hospitals, Jaipur organized an interactive session featuring world renowned cardiologist Dr. Samir Kapadia, Chairman of Cardiovascular Medicine and Director of Cardiology at Cleveland Clinic in the USA.
Senior cardiologists of CK Birla Hospitals, engaged with Dr Kapadia from Cleveland Clinic, which is recognized as a top heart hospital in the U.S. for more than 30 consecutive years, to deliberate on emerging trends shaping heart care worldwide. The discussion focused on topics such as minimally invasive valve therapies, structural heart interventions, innovations in cardiac imaging, and how artificial intelligence is beginning to transform early diagnosis and risk prediction. Specialists also addressed the rising heart disease burden in India and explored ways in which global treatment protocols can be adapted for the country’s unique patient profile.
Dr. Kapadia’s session was attended by leading cardiologists and cardiac surgeons across the CK Birla Hospitals and facilitated by Deepika Grandhi, Cleveland Clinic India representative. Together, they exchanged insights on translating cutting-edge international practices into the Indian context, with a focus on strengthening outcomes and improving long-term patient care.
Vipul Jain, CEO, CK Birla Hospitals, said, “Sessions such as this reflect our shared commitment to advancing cardiac care in India. By bringing together specialists from CK Birla Hospitals and Cleveland Clinic, we are able to jointly examine and assess cutting-edge advancements, adapt them to the Indian setting, and reinforce our role in treating one of the world’s fastest-growing heart disease populations.”
